168 related articles for article (PubMed ID: 36721233)
1. High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy.
Xu X; Wei F; Xiao L; Wu R; Wei B; Huang S; Yi J; Cui W
J Transl Med; 2023 Jan; 21(1):64. PubMed ID: 36721233
[TBL] [Abstract][Full Text] [Related]
2. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
[TBL] [Abstract][Full Text] [Related]
4. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.
Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
Oncotarget; 2016 Jul; 7(29):46653-46661. PubMed ID: 27270307
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
Lu ZJ; Liu LT; Sun XS; Guo SS; Yang Q; Liu SL; Li XY; Qiu HZ; Yang ZC; Xiao BB; Lin C; Luo DH; Sun R; Lin HX; Chen QY; Tang LQ; Guo L; Mai HQ
Radiother Oncol; 2021 Sep; 162():202-211. PubMed ID: 33839207
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
Chen WH; Tang LQ; Guo SS; Chen QY; Zhang L; Liu LT; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
Medicine (Baltimore); 2016 Feb; 95(5):e2642. PubMed ID: 26844482
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
8. Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy.
Yang L; Hong S; Wang Y; Chen H; Liang S; Peng P; Chen Y
Sci Rep; 2015 Oct; 5():15638. PubMed ID: 26497224
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma.
Zhang Y; Zhu Y; Wang J; Xu Y; Wang Z; Liu Y; Di X; Feng L; Zhang Y
Cancer Immunol Immunother; 2022 Mar; 71(3):675-688. PubMed ID: 34342668
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pan-immune-inflammation value (PIV) in nasopharyngeal carcinoma patients.
Zhang N; Hou T; Zhang S; Ling J; Jiang S; Xie Y; Liu X; Hu C; Feng Y
Heliyon; 2024 Jan; 10(2):e24804. PubMed ID: 38312571
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y
Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
[TBL] [Abstract][Full Text] [Related]
13. Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
Mao JR; Lan KQ; Liu SL; Liu C; Xie SY; Li SC; Ye WF; Sun XS; Mai HQ
Radiother Oncol; 2023 Feb; 179():109445. PubMed ID: 36566987
[TBL] [Abstract][Full Text] [Related]
14. Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study.
Du YY; Luo DH; Sun XS; Tang LQ; Mai HQ; Chen QY; Zhong JH; Mai DM; Zhang WR; Chen WH; Mo HY
Cancer Med; 2019 Nov; 8(16):6841-6852. PubMed ID: 31513364
[TBL] [Abstract][Full Text] [Related]
15. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang H; Zhang R; Zhang R; Zhang B; Xie Y; Qin G; Mo Y; Ruan X; Jiang W
Strahlenther Onkol; 2022 Sep; 198(9):828-837. PubMed ID: 35384452
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
[TBL] [Abstract][Full Text] [Related]
18. Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Tang LQ; Hu DP; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Wen SH; Peng YT; Chen WH; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mai HQ
PLoS One; 2015; 10(4):e0122965. PubMed ID: 25874450
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
20. Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.
Huang C; Ding J; Huang C; Yu L; Chitapanarux I; Mejia MBA; Fei Z; Chen C
Transl Cancer Res; 2023 Dec; 12(12):3718-3727. PubMed ID: 38192995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]